Asarina Pharma   Report issue

For profit Phase 2
Founded: Solna Sweden (2006)

Organization Overview

First Clinical Trial
2013
NCT01875718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Asarina Pharma